Clinuvel Pharmaceuticals Ltd. Sponsored ADR (CLVLY)
Market Open
10 Aug, 01:30 PM
$
6. 74
+0.07
+0.9738%
$
339.88M Market Cap
- P/E Ratio
0.12% Div Yield
152 Volume
- Eps
$ 6.67
Previous Close Want to track CLVLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Clinuvel Pharmaceuticals Ltd. Sponsored ADR (CLVLY) Statistics
Valuation metrics
Market Cap 339.88M
Enterprise value 450.65M
Trailing P/E (ttm) 14.84
Forward P/E -
PEG ratio -0.95
Price/Sales (ttm) 5.09
Price/Book (mrq) 1.94
Enterprise Value/Revenue 4.71
Enterprise Value/EBITDA 10.87
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8K
Average volume (90 days) 14.81K
Price summary
52-Week low 5.98
52-Week high 9
Beta -
50-Day moving average 6.26
200-Day moving average 6.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.05
Trailing annual dividend yield 0.0053%
5-Year annual dividend yield -
Payout ratio 0.08
Dividend Date 28 Sep 2026
Ex-Dividend Date 8 Sep 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.34%
Operating margin 0.39%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.91
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.64
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 14.64%
Book value per share (mrq) 4.96
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
